Gouty Arthritis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Gouty Arthritis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, July 22, 2024 /EINPresswire.com/ -- The global gouty arthritis market is set to grow from $3.21 billion in 2023 to $3.44 billion in 2024, at a compound annual growth rate (CAGR) of 7.2%. This growth trajectory is expected to continue, with the market reaching $4.57 billion by 2028 at a CAGR of 7.3%, driven by factors such as increasing obesity rates, advancements in healthcare infrastructure, and heightened awareness of gout and its treatment.

Rising Prevalence of Obesity Drives Market Growth

The increasing prevalence of obesity is a major factor driving the growth of the gouty arthritis market. Obesity, characterized by an excessive buildup of body fat, is linked to a higher production of uric acid and reduced excretion, which leads to the accumulation of uric acid crystals in joints. This exacerbates inflammation and pain associated with gout. According to the World Health Organization, around 1 billion individuals were classified as obese in March 2022, and this figure is projected to rise, emphasizing the need for effective gouty arthritis treatments.

Explore comprehensive insights into the global gouty arthritis market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=16070&type=smp

Key Players and Market Trends

Major companies in the gouty arthritis market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., and Lupin Pharmaceuticals Inc. These companies are focusing on developing novel therapies, such as Cortrophin Gel, which received FDA approval in October 2023 for the adjunctive treatment of acute gouty arthritis flares.

Major Trends in the Market

The forecast period will witness several significant trends, including a growing demand for effective treatment options, advancements in regenerative therapies, and increased product launches and regulatory approvals. These trends reflect the ongoing efforts to improve treatment outcomes for gouty arthritis and address the rising incidence of the condition.

Segments:

• Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
• Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
• Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
• Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
• End-Users: Hospitals, Specialty Clinics, Other End-Users

Geographical Insights: North America Leading, Europe Fastest-Growing

North America was the largest region in the gouty arthritis market in 2023. However, Europe is expected to be the fastest-growing region during the forecast period, driven by increasing awareness and improved healthcare infrastructure.

Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Gouty Arthritis Global Market Report 2024 from TBRC covers the following information:

Market size data for the forecast period: Historical and Future
Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Gouty Arthritis Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on gouty arthritis market size, gouty arthritis market drivers and trends, gouty arthritis market major players, competitors' revenues, market positioning, and market growth across geographies. The gouty arthritis market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Arthritis Monoclonal Antibodies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Psoriatic Arthritis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Rheumatoid Arthritis Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports covering 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.